111 related articles for article (PubMed ID: 16955460)
1. Retinoblastoma-related geneRb2/p130 are rarely mutated in Burkitt's lymphoma from Brazil.
Klumb CE; Magluta EP; Rezende LM; Apa AG; Alonso JF; Maia RC
Am J Hematol; 2007 Mar; 82(3):238-9. PubMed ID: 16955460
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors.
Cinti C; Claudio PP; Howard CM; Neri LM; Fu Y; Leoncini L; Tosi GM; Maraldi NM; Giordano A
Cancer Res; 2000 Jan; 60(2):383-9. PubMed ID: 10667591
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.
Cinti C; Leoncini L; Nyongo A; Ferrari F; Lazzi S; Bellan C; Vatti R; Zamparelli A; Cevenini G; Tosi GM; Claudio PP; Maraldi NM; Tosi P; Giordano A
Am J Pathol; 2000 Mar; 156(3):751-60. PubMed ID: 10702389
[TBL] [Abstract][Full Text] [Related]
4. Lack of Rb2/p130 genetic alteration in Malaysian nasopharyngeal carcinoma.
Hoe SL; Lee ES; Khoo AS; Peh SC
Malays J Pathol; 2009 Jun; 31(1):53-6. PubMed ID: 19694314
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma-related gene RB2/p130 exons 19-22 are rarely mutated in glioblastomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Alonso ME; Lomas J; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
Oncol Rep; 2002; 9(5):951-4. PubMed ID: 12168053
[TBL] [Abstract][Full Text] [Related]
6. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma.
Claudio PP; Howard CM; Fu Y; Cinti C; Califano L; Micheli P; Mercer EW; Caputi M; Giordano A
Cancer Res; 2000 Jan; 60(1):8-12. PubMed ID: 10646842
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of p53 and RB2/p130 genes in Malaysian nasopharyngeal carcinoma samples: a preliminary report.
Hoe SL; Sam CK
Malays J Pathol; 2006 Jun; 28(1):35-9. PubMed ID: 17694957
[TBL] [Abstract][Full Text] [Related]
9. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.
Yano T; Sander CA; Clark HM; Dolezal MV; Jaffe ES; Raffeld M
Oncogene; 1993 Oct; 8(10):2741-8. PubMed ID: 8397370
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer.
Claudio PP; Howard CM; Pacilio C; Cinti C; Romano G; Minimo C; Maraldi NM; Minna JD; Gelbert L; Leoncini L; Tosi GM; Hicheli P; Caputi M; Giordano GG; Giordano A
Cancer Res; 2000 Jan; 60(2):372-82. PubMed ID: 10667590
[TBL] [Abstract][Full Text] [Related]
11. Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer.
Alvi AJ; Hogg R; Rader JS; Kuo MJ; Maher ER; Latif F
Mol Pathol; 2002 Jun; 55(3):153-5. PubMed ID: 12032225
[TBL] [Abstract][Full Text] [Related]
12. Selective expression of one c-myc allele in two human myeloma cell lines.
Kuehl WM; Brents LA; Chesi M; Bergsagel PL
Cancer Res; 1996 Oct; 56(19):4370-3. PubMed ID: 8813127
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the retinoblastoma-related gene RB2/p130 in adult T-cell leukaemia/lymphoma.
Takeuchi S; Takeuchi N; Tsukasaki K; Fermin AC; De Vas S; Seo H; Koeffler HP
Leuk Lymphoma; 2003 Apr; 44(4):699-701. PubMed ID: 12769348
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma.
Nomdedéu JF; Lete I; Baiget M; Lasa A; Estivill C; Rubiol E; Badell I; Pardo N; Cubells J; Mateu R; Brunet S; Bordes R; Soler J
Haematologica; 1997; 82(5):550-4. PubMed ID: 9407719
[TBL] [Abstract][Full Text] [Related]
15. Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors.
De Falco G; Leucci E; Lenze D; Piccaluga PP; Claudio PP; Onnis A; Cerino G; Nyagol J; Mwanda W; Bellan C; Hummel M; Pileri S; Tosi P; Stein H; Giordano A; Leoncini L
Blood; 2007 Aug; 110(4):1301-7. PubMed ID: 17485552
[TBL] [Abstract][Full Text] [Related]
16. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors.
Bhatia KG; Gutiérrez MI; Huppi K; Siwarski D; Magrath IT
Cancer Res; 1992 Aug; 52(15):4273-6. PubMed ID: 1638540
[TBL] [Abstract][Full Text] [Related]
17. A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma.
Bhatia K; Fan S; Spangler G; Weintraub M; O'Connor PM; Judde JG; Magrath I
Cancer Res; 1995 Apr; 55(7):1431-5. PubMed ID: 7882347
[TBL] [Abstract][Full Text] [Related]
18. Dok1 expression and mutation in Burkitt's lymphoma cell lines.
Lee S; Huang H; Niu Y; Tommasino M; Lenoir G; Sylla BS
Cancer Lett; 2007 Jan; 245(1-2):44-50. PubMed ID: 16338067
[TBL] [Abstract][Full Text] [Related]
19. What is Burkitt's lymphoma?
Wright DH
J Pathol; 1997 Jun; 182(2):125-7. PubMed ID: 9274520
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
Preudhomme C; Dervite I; Wattel E; Vanrumbeke M; Flactif M; Lai JL; Hecquet B; Coppin MC; Nelken B; Gosselin B
J Clin Oncol; 1995 Apr; 13(4):812-20. PubMed ID: 7707106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
